BCTX

Briacell Therapeutics CORP

+$1.6M

Net Activity

Institutions Holding

16

Popularity Rank

#8739

Avg Weight

0.25%

Total Value

$1.6M

Ownership Trend

16 institutions currently hold BCTX, with 7 net buyers and 5 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Increased

Based on recent trading activity

Net Selling Institutions

5

Net Buying Institutions

7

Key Holders

View all 16 holding institutions

Quarterly Activity

Recent Activity

+$1.6M

Total Buy Value

$62.5K

Total Sell Value

New buy6
Trim3
Add1
Sold out2

7

Net Buyers

5

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding BRIACELL THERAPEUTICS CORP (BCTX)?
Major stakeholders currently include Cable Car Capital, LP ($908.5K), Sabby Management, LLC ($309.7K), Iridian Asset Management Llc/ct ($272.4K). Based on the latest 13F filings, there are a total of 16 tracked investment funds and institutions maintaining positions in BCTX.
What is the overall institutional sentiment toward BCTX recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $1.6M, driven by 7 managers accumulating shares while 5 reduced their exposure.
Which institutions have been selling or reducing their BCTX positions?
In the latest period, 3 funds trimmed their holdings, and 2 managers completely exited their positions. The aggregate reported sell value was $62.5K.
Are there any notable investors adding BCTX to their portfolios?
Yes, buying activity remains notable. 6 institutions opened new positions in {ticker}, and 1 existing holders added to their shares. The total reported buy value for the quarter amounted to $1.6M.

Related Stocks